Thromb Haemost 1969; 22(01): 164-173
DOI: 10.1055/s-0038-1651337
Originalarbeiten-Original Articles-Travaux Originaux
Schattauer GmbH

Platelet Adhesiveness and Euglobulin Lysis Time in Dogs Given Repeated Infusion of Sodium Palmitate

M Cucuianu
1   Institute of Medical Research of the Rumanian Academy, Medical Clinic I, Cluj (Rumania)
,
V. V Papilian
1   Institute of Medical Research of the Rumanian Academy, Medical Clinic I, Cluj (Rumania)
,
N Bareliuc
1   Institute of Medical Research of the Rumanian Academy, Medical Clinic I, Cluj (Rumania)
,
I Crisnic
1   Institute of Medical Research of the Rumanian Academy, Medical Clinic I, Cluj (Rumania)
› Author Affiliations
Further Information

Publication History

Publication Date:
10 June 2018 (online)

Summary

The effect of infusions with sodium palmitate 3.5 m Mol/1 on platelet adhesiveness and euglobulin lysis time was studied in 16 dogs. A decrease of platelet adhesiveness was noted 15 min after infusion. Decreased platelet adhesiveness persisted 3 and 24 hrs later, although platelet counts that were diminished 15 min after the infusion, returned to the initial level. Fibrinogen levels were not found to decrease during infusions of fatty acids. A progressive increase of plasma fibrinogen was even noted in animals that survived more than 7 days after the first infusion. Following a transient acceleration of euglobulin lysis time, a delayed fibrinolysis was noted, probably as a result of the exhaustion of blood activator.

Fibrin depositions were emphasized in histological sections. In some animals aspects of obliterative thromboangiitis were noted. However bilateral cortical necrosis was found in only 1 dog.

It seems that correlations between increased lipid mobilization and changes of coagulability and fibrinolysis in atherosclerosis are much more complex.

 
  • References

  • 1 Beller F. K, Mitchell P. S, Gorstein F. Fibrin deposition in the rabbit kidney produced by protease inhibitors. Thrombos. Diathes. haemorrh. (Stuttg.) 17: 427 1967;
  • 2 Carlson L. A, Böberg I, Hogstedt B. Some physiological and clinical implication of lipid mobilization from adipose tissue. In: Field J, Magoun H. W, and Hall V. E. (EDS) Handbook of Physiology, sect. 5 (Adipose Tissue). Amer. Physiol. Soc. Washington D. C.: 63 625 1965
  • 3 Connor W. E. The acceleration of thrombus formation by certain fatty acids. J. clin. Invest. 41: 1199 1962;
  • 4 Connor W. E, Hoak J. C, Warner E. D. The role of lipids in thrombosis. In pathogenesis and treatment of thromboembolic diseases. Thrombos. Diathes. haemorrh. Suppl. 17: 193 1966;
  • 5 Cucuianu M. Betalipoproteins and euglobulin lysis time. Thrombos. Diathes. haemorrh. (Stuttg.) 16: 687 1966;
  • 6 Haslam R. J. Role of adenosine diphosphate in the aggregation of human blood platelets by thrombin and by fatty acids. Nature (Lond.) 202: 765 1964;
  • 7 Hoak J. D, Connor W. E, Eckstein J. W, Warner E. D. Fatty acids induced thrombosis and death. Mechanism and prevention. J. Lab. clin. Med. 63: 791 1964;
  • 8 Lasch H. G. Zur Pathophysiologie und Klinik des Sanarelli-Shwartzman-Phänomens. In: Das Sanarelli-Shwartzman-Phänomen ; Biochemie und Kinetik des antih ämophilen Globulins ; Blutungen bei portaler Hypertension. F. K. Schattauer; Stuttgart: 1964
  • 9 Lee L. Reticuloendothelial clearance of circulating fibrin in the pathogenesis of the generalized Shwartzman reaction. J. exp. Med. 115: 1065 1962;
  • 10 Levin J, Back E. A re-appraisal of the role of blood coagulation and platelets in the generalized Shwartzman Phenomenon Thrombos. Diathes. haemorrh. (Stuttg.) 15: 517 1966;
  • 11 Moga A, Cucuianu M, Crisnic I, Olinic N. Platelet adhesiveness during different evolutive stages of atherosclerosis; correlation with changes of serum lipids. Rev. Roum. Med. int. 3: 407 1966;
  • 12 Mustard J. F. Platelets, thrombosis and vascular disease. Canad. med. Ass. J. 85: 621 1961;
  • 13 Novak M. Colorimetrie ultramicromethod for the determination of free fatty acids. J. Lipid. Res. 6: 431 1965;
  • 14 Owren P. A. Coronary thrombosis its mechanism and possible prevention by linolenic acid. Ann. intern, med. 63: 176 1965;
  • 15 Pilgeram L. O, Pickart L. R. Control of fibrinogen biosynthesis: the role of free fatty acid. J. Atheroscler. Res. 8: 59 1968;
  • 16 Poole J. C. F. Effect of Certain fatty acids on the coagulation of plasma in vitro. Brit. J. exp. Path. 36: 245 1955;
  • 17 Ratnoff O. D, Menzie C. A new method for the determination of fibrinogen in small samples of plasma. J. Lab. Clin. Med. 37: 316 1951;
  • 18 Rodriguez-Erdmann F, Lasch H. G. Quantitative and qualitative Störungen der Thrombo-cyten nach Injektion hochmolekularer Polymeren. Thrombos. Diathes. haemorrh. (Stuttg.) 5: 518 1961;
  • 19 Rodriguez-Erdmann F. Studies on the pathogenesis of the generalized Shwartzman reaction. Thrombos. Diathes. haemorrh. (Stuttg.) 12: 462 1964;
  • 20 Selye H. Thrombohemorrhagic Phenomena. C. H. Thomas Publisher; Springfield, Illinois, U.S.A.: 1966
  • 21 Soloff L. A, Fawell W, Day H.J. Nonthrombogenic effect of chronic slow infusions of long chain saturated fatty acids. Amer. J. med. Sci. 253/1: 94 1967;
  • 22 Spöttl F, Holzknecht F. Über die Antiplasminaktivität verschiedener Lipide in vitro. Wien, klinisch. Wschr. 80: 338 1968;
  • 23 Steichele D. T, Herschlein H. J. Untersuchungen über die Fibrinolyse bei Äquivalenten des Sanarelli-Shwartzman Phänomen in der Geburtshilfe. Immunochemischer Nachweis von Fibrin(ogen)derivaten. Thrombos. Diathes. haemorrh. (Stuttg.) 18: 311 1967;
  • 24 Von Kaulla K. Chemistry of thrombolysis. Human Fibrinolytic Enzymes. Ch. C. Thomas Publisher; Springfield Illinois U.S.A.: 1963
  • 25 Weber E, Malessa S, Lasch H. G. Veränderungen der freien Thrombozytennukleotide beim Sanarelli-Shwartzman-Phänomen. Thrombos. Diathes. haemorrh. (Stuttg.) 9: 304 1963;
  • 26 Warren B. A. Fibrinolytic activity of vascular endothelium. Brit. med. Bull. 20: 213 1964;
  • 27 Wright H. P. Adhesiveness of blood platelets in normal subjects and with varying concentrations of anticoagulants. J. Path. Bact. 53: 255 1941;
  • 28 Zbinden G. Transient thrombopenia after intravenous injection of certain fatty acids. J. Lipid. Res. 5: 378 1964;